US Patent Issued to RESET PHARMACEUTICALS on Feb. 24 for "Co-crystals or salts of psilocin and methods of treatment therewith" (British Inventors)

ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,559,458, issued on Feb. 24, was assigned to RESET PHARMACEUTICALS INC. (New York).

"Co-crystals or salts of psilocin and methods of treatment therewith" was invented by John Knight (Hereford, Great Britain) and Talbir Austin (Loughborough, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to a co-crystal or salt comprising psilocin and a co-former. The co-crystal or salt is useful in methods of treating or preventing a disease or condition selected from depression, anxiety, death anxiety, demoralization, adjustment disorders, hopelessness, suicidal ideation, desire for hastened death, cocaine-related disorders, opioid-re...